EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects

Chithra K Pushpan, Subramanyan Ram Kumar iD

Cells · 2024

DOI: 10.3390/cells13171430 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Chithra K Pushpan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, Department of Surgery, University of Nebraska Medical Center, Omaha, NE 68198-7616, USA. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Induced Pluripotent Stem Cells, Heart Defects, Congenital, Cell Differentiation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Children’s Health Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The discovery of human pluripotent stem cells (hiPSCs) and advances in DNA editing techniques have opened opportunities for personalized cell-based therapies for a wide spectrum of diseases. It has gained importance as a valuable tool to investigate genetic and functional variations in congenital heart defects (CHDs), enabling the customization of treatment strategies. The ability to understand the disease process specific to the individual patient of interest provides this technology with a significant advantage over generic animal models. However, its utility as a disease-in-a-dish model requires identifying effective and efficient differentiation protocols that accurately reproduce disease traits. Currently, iPSC-related research relies heavily on the quality of cells and the properties of the differentiation technique In this review, we discuss the utility of iPSCs in bench CHD research, the molecular pathways involved in the differentiation of cardiomyocytes, and their applications in CHD disease modeling, therapeutics, and drug application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacInduced Pluripotent Stem CellsHeart Defects, CongenitalCell DifferentiationHumansAnimalsModels, Biological

Stichwörter der Autor:innen

TOFcardiomyocytecongenital heart diseasesdisease modeliPSC

Autor:innen und Institutionen

  • Division of Cardiothoracic Surgery, Department of Surgery, University of Nebraska Medical Center, Omaha, NE 68198-7616, USA.
  • Dr. C.C. and Mabel, L. Criss Heart Center, Children's Nebraska, 8200 Dodge St, Omaha, NE 68114, USA.

ORCID-Profile: Subramanyan Ram Kumar

Förderung

  • Children’s Health Research Institute

Zitieren

APA

Pushpan, C. K., & Kumar, S. R. (2024). iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects. Cells. https://doi.org/10.3390/cells13171430

Vancouver

Pushpan CK, Kumar SR. iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects. Cells. 2024. doi:10.3390/cells13171430

BibTeX
@article{Pushpan2024,
  author = {Pushpan, Chithra K and Kumar, Subramanyan Ram},
  title = {iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13171430}
}
Kostenlos starten →